Biotech Values

[mcbio]

Re: LGND/Promacta

$400M in peak annual sales.

Thanks Dew. I would imagine that a level of $400M in annual sales would probably put the royalties due to LGND at the lower-end range of the royalties of 4.7-9.3% of annual net sales that LGND would earn. If we assume 5% to be conservative, that's just an annual revenue stream of $20M for LGND. That's probably not much to be excited about, although LGND does have an extensive pipeline now with all of these acquisitions they have been doing. See: http://www.ligand.com/media/PIPELINE_Nov_2009.pdf . The question remains whether or not these projects represent mostly quantity or if there is some real quality in there.